Födinger M - Search Results

1

Genetic aspects of hyperhomocysteinemia in chronic kidney disease.

Sunder-Plassmann G, Winkelmayer WC, Födinger M. Sunder-Plassmann G, et al. Among authors: fodinger m. Semin Nephrol. 2006 Jan;26(1):8-13. doi: 10.1016/j.semnephrol.2005.06.003. Semin Nephrol. 2006. PMID: 16412818 Review.

2

Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study.

Sunder-Plassmann G, Födinger M, Buchmayer H, Papagiannopoulos M, Wojcik J, Kletzmayr J, Enzenberger B, Janata O, Winkelmayer WC, Paul G, Auinger M, Barnas U, Hörl WH. Sunder-Plassmann G, et al. Among authors: fodinger m. J Am Soc Nephrol. 2000 Jun;11(6):1106-1116. doi: 10.1681/ASN.V1161106. J Am Soc Nephrol. 2000. PMID: 10820175 Clinical Trial.

3

Genetic determinants of the homocysteine level.

Sunder-Plassmann G, Födinger M. Sunder-Plassmann G, et al. Among authors: fodinger m. Kidney Int Suppl. 2003 May;(84):S141-4. doi: 10.1046/j.1523-1755.63.s84.52.x. Kidney Int Suppl. 2003. PMID: 12694331 Free article. Review.

4

Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.

Winkelmayer WC, Kramar R, Curhan GC, Chandraker A, Endler G, Födinger M, Hörl WH, Sunder-Plassmann G. Winkelmayer WC, et al. Among authors: fodinger m. J Am Soc Nephrol. 2005 Jan;16(1):255-60. doi: 10.1681/ASN.2004070576. Epub 2004 Nov 24. J Am Soc Nephrol. 2005. PMID: 15563562

5

Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients.

Winkelmayer WC, Huber A, Wagner OF, Hörl WH, Sunder-Plassmann G, Födinger M. Winkelmayer WC, et al. Among authors: fodinger m. Kidney Int. 2005 May;67(5):1980-5. doi: 10.1111/j.1523-1755.2005.00298.x. Kidney Int. 2005. PMID: 15840047 Free article.

6

Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients.

Winkelmayer WC, Kramar R, Sunder-Plassmann G, Födinger M. Winkelmayer WC, et al. Among authors: fodinger m. Kidney Int. 2005 Dec;68(6):2857-62. doi: 10.1111/j.1523-1755.2005.00759.x. Kidney Int. 2005. PMID: 16316363 Free article.

7

No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients.

Riegersperger M, van Houte M, Födinger M, Wojcik J, Hörl WH, Winkelmayer WC, Sunder-Plassmann G. Riegersperger M, et al. Among authors: fodinger m. Am J Nephrol. 2007;27(4):390-6. doi: 10.1159/000104256. Epub 2007 Jun 21. Am J Nephrol. 2007. PMID: 17587788

8

Pathophysiology and clinical importance of hyperhomocysteinemia: clinical intervention studies.

Sunder-Plassmann G, Födinger M. Sunder-Plassmann G, et al. Among authors: fodinger m. Miner Electrolyte Metab. 1999 Jul-Dec;25(4-6):286-90. doi: 10.1159/000057461. Miner Electrolyte Metab. 1999. PMID: 10681653 Review.

9

Molecular biology of 5,10-methylenetetrahydrofolate reductase.

Födinger M, Hörl WH, Sunder-Plassmann G. Födinger M, et al. J Nephrol. 2000 Jan-Feb;13(1):20-33. J Nephrol. 2000. PMID: 10720211 Review.

10

Hyperhomocysteinemia in organ transplantation.

Sunder-Plassmann G, Floth A, Födinger M. Sunder-Plassmann G, et al. Among authors: fodinger m. Curr Opin Urol. 2000 Mar;10(2):87-94. doi: 10.1097/00042307-200003000-00007. Curr Opin Urol. 2000. PMID: 10785848 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters